1. Macrophage Migration Inhibitory Factor (MIF) and D-Dopachrome Tautomerase (DDT): Pathways to Tumorigenesis and Therapeutic Opportunities
   Caroline Naomi Valdez et al, 2024, International Journal of Molecular Sciences CrossRef
2. Multimodal MRI for Estimating Her-2 Gene Expression in Endometrial Cancer
   Xiwei Li et al, 2023, Bioengineering CrossRef
3. Identifying clinical features and molecular characteristics of the endometrial clear cell carcinoma
   Yuhan Cai et al, 2023, Frontiers in Oncology CrossRef
4. The Combination of circEPSTI1 and MIF Offers Diagnostic Value for Endometrial Cancer
   Zhili Cui et al, 2024, International Journal of General Medicine CrossRef
5. Prognostic value of an autophagy-related gene expression signature for endometrial cancer patients
   Hui Wang et al, 2020, Cancer Cell International CrossRef
6. Haplotypes of [‐794(CATT)5–8/‐173G>C] MIF gene polymorphisms and its soluble levels in cutaneous squamous cell carcinoma in western Mexican population
   Elizabeth Guevara‐Gutiérrez et al, 2023, Molecular Genetics & Genomic Medicine CrossRef
7. High throughput silencing identifies novel genes in endometrioid endometrial cancer
   Afiqah Alyaa Md Fuzi et al, 2018, Taiwanese Journal of Obstetrics and Gynecology CrossRef
8. Influence of Epstein–Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma
   Guofei Feng et al, 2021, BMC Cancer CrossRef
9. The Prognostic Effect of HER2 Gene Amplification in High-Grade Endometrial Carcinomas and its Correlation with Protein Overexpression
   Kemal Kürşat Bozkurt et al, 2023, International Journal of Surgical Pathology CrossRef
10. MIF-Dependent Control of Tumor Immunity
    Jordan T. Noe et al, 2020, Frontiers in Immunology CrossRef
11. Prognostic value of microcirculatory changes and alterations in the cellular microenvironment in patients with glandular hyperplasia of the endometrium and endometrial cancer (literature review)
    Yu. S. Korneva et al, 2019, Tumors of female reproductive system CrossRef
12. CMBs carrying PTX and CRISPR/Cas9 targeting C‑erbB‑2 plasmids interfere with endometrial cancer cells
    Siyuan Peng et al, 2021, Molecular Medicine Reports CrossRef
13. Elucidation of HER2/neu and Wilms’ tumor 1 immunohistochemical expression in endometrial carcinomas regarding the diagnostic and prognostic significance
    MarwaA El Kholy et al, 2022, Egyptian Journal of Pathology CrossRef